Our Platform
Enabling safer treatments for a broader range of diseases.
ABOUT US
We are making gene therapy safer
Concinnity is transforming the safety of gene therapies by designing novel control mechanisms using its cutting-edge AI platform and synthetic biology expertise.
These unique RNA-based systems enable the precise control of gene therapies even after dosing, conveying the ability to respond to and reduce their own side effects.
GENE THERAPY
Realise a new era in gene therapy innovation
Safety concerns remain a major issue in gene therapies. Therapies need to incorporate gene control systems to mitigate side effects and enable their application to a broader range of diseases.
WORK WITH US
Our partnership models
Concinnity is the go-to partner for gene control in gene and cell therapy. We empower our visionary partners to design and optimise their gene therapies in the confidence that they will be making them as safe as possible. We offer a range of partnership models to suit your development needs.
Realise a new era in gene therapy
Partner with Concinnity to enhance the safety and expand the applications of your gene therapies.